impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Global microRNA profiling of peripheral blood mononuclear cells in patients with Behçet's disease.

1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11

 

  1. Cattedra e Unità di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università e AOU di Sassari, Italy. e.gianluca@libero.it
  2. Cattedra e Unità di Reumatologia, Dipartimento di Scienze Mediche, Università e AOU di Cagliari, Monserrato, Italy.
  3. Dipartimento di Scienze Biomediche, Università di Sassari, Italy.
  4. Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, Monserrato; and CRS4, Parco Tecnologico della Sardegna, Pula, Italy.
  5. Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, Monserrato, Italy.
  6. Cattedra e Unità di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università e AOU di Sassari, Italy.
  7. Dipartimento di Scienze Biomediche, Università di Sassari, Italy.
  8. Dipartimento di Scienze Biomediche, Università di Sassari, Italy.
  9. Cattedra e Unità di Reumatologia, Dipartimento di Scienze Mediche, Università e AOU di Cagliari, Monserrato, Italy.
  10. Cattedra e Unità di Reumatologia, Dipartimento di Medicina Clinica e Sperimentale, Università e AOU di Sassari, Italy.
  11. Health e-solutions, Rotterdam, The Netherlands.

CER8059
2015 Vol.33, N°6 ,Suppl.94
PI 0072, PF 0079
Full Papers

Free to view
(click on article PDF icon to read the article)

PMID: 26486198 [PubMed]

Received: 25/10/2014
Accepted : 27/05/2015
In Press: 19/10/2015
Published: 04/11/2015

Abstract

OBJECTIVES:
To explore the post-transcriptional regulation of the peripheral blood mononuclear cells (PBMCs) transcriptome by microRNAs in Behçet’s disease (BD).
METHODS:
Using TaqMan Low Density Array-based microRNAs expression profiling, the expression of 750 mature human microRNAs in PBMCs from 5 BD patients and 3 healthy controls (HC) was compared. The expression of deregulated microRNAs was then validated by quantitative real time-poly-merase chain reaction (qRT-PCR), in 42 BD patients and 8 HC.
RESULTS:
In the initial screening, 13 microRNAs appeared deregulated in BD vs HC. Among them, the differential expression of miR-720 and miR-139-3p was confirmed by qRT-PCR, (p<0.05 and FDR <5%). Areas under the receiver operating characteristic curve for miR-139-3p, miR-720 and miR-139-3p + miR-720 in the validation cohort were 0.84, 0.87 and 0.92 respectively, indicating good discrimination between BD patients and HC. Post-hoc analysis showed that 9 out of 13 microRNAs from the discovery phase were significantly upregulated in active vs. quiescent BD, suggesting inflammation as a key regulator of microRNAs machinery in BD. In silico analysis revealed that several BD candidate susceptibility genes are predicted target of significantly deregulated microRNAs in active BD. A significant enrichment in microRNAs targeting elements of the Toll-like receptor (TLR) and T-cell receptor signalling pathways was also assumed.
CONCLUSIONS:
miR199-3p and miR720 deserve further confirmation as biomarkers of BD in larger studies. PBMCs from active BD displayed a unique signature of microRNAs which may be implicated in regulation of innate immunity activation and T-cell function.

Rheumatology Article